SNS Insider Reports: Increasing Awareness, Advancements in Drug Development, and government Initiatives fuel market Growth at a CAGR of 4.06% from 2024-2032 ...

BD affects millions but remains misunderstood, underdiagnosed, and underfunded. Researchers are working to change this by ...

However, we still see areas of weakness in the portfolio, including upcoming patent losses and a highly uncertain pipeline due to the complexities of running CNS trials. Historically, the firm ...

Gabapentinoids are increasingly prescribed as an alternative to pain medicines for nursing home residents, but the reasoning behind the prescriptions — and beliefs about efficacy and deprescribing — ...

Recent studies have shown that antioxidant compounds such as NAC could be beneficial in limiting seizure activity and improving the anticonvulsant efficacy of GABA-mediating drugs such as diazepam.

The Company will be focusing on the following programs with Bucillamine: Revive is targeting nerve agent exposure as its initial indication for its medical countermeasures program. Nerve agents are ...

Finding the right path for you can take some time. Once you’re diagnosed with epilepsy, your healthcare provider’s first act will likely be prescribing anti-seizure medication (antiepileptic drugs) to ...

The 34-year-old, who cannot be named to protect the identity of the child, appeared in the Brisbane Magistrates Court on Tuesday, where she made an application for bail.

A Queensland social media influencer is accused of drugging her 18-month-old daughter with anticonvulsant medication ... and had been prescribed the drug carbamazepine. Her medical team suspected ...

C&EN’s tabulation follows approvals from the FDA’s Center for Drug Evaluation and Research; therefore, it does not include blood products, gene therapies, vaccines, and other therapies that ...

Clinical trials of the first drugs designed with the help of artificial intelligence could commence this year, Google DeepMind CEO Demis Hassabis suggested Tuesday. Speaking on a panel at the World ...